The Pipeline

Home>News>The Pipeline

Combining new and existing immunity: a 3D approach to killing cancer

by Richard Boyd and Aleta Pupovac

A question which has long baffled scientists, frustrated clinicians and devastated patients is why does the immune system so effectively defend against infections but so poorly deal with cancer? What lessons can be learnt?

Thanks to a molecular biology-led revolution in immunotherapy, we are now beginning to strategically apply the immune […]

2023-09-25T08:03:23+10:00September 25th, 2023|

Bio Connections Australia 2023 promotes science commercialisation

Commercialising science and technology is key to the continued growth of Australia’s vibrant life sciences industry. Translating research into real-world results has important implications for consumers and businesses alike.

Bio Connections Australia 2023 was held today at Crown Promenade Melbourne with an important focus on translation, drug development and expediting Australia’s science into commercialisation.

The forum […]

2023-07-31T16:08:33+10:00July 31st, 2023|

Australia – China Science and Innovation Forum fosters collaboration and commercialisation

The 2023 Australia-China Science and Innovation Forum focused on leading-edge Australian and Chinese biomedical research collaborations and commercialisation. The forum was held at Monash University’s Suzhou campus in China last week and was also available for online attendance.

The forum’s program was designed to promote connections and enhance collaborations between the Australian and Chinese research and […]

2023-06-28T11:13:35+10:00June 28th, 2023|

Global IP takes centre stage at the 21st Advanced Summit on Life Sciences Patents

Cartherics’ Director of IP & Licensing, Telma Mantas recently attended the ACI’s 21st Advanced Summit on Life Sciences Patents in New York City. The summit provided the opportunity to engage in face-to-face discussions with leading stakeholders on the best practices to enhance global protections for patent portfolios. Now more than ever in these increasingly […]

2023-05-30T15:08:10+10:00May 30th, 2023|

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

Melbourne, Australia, 28 April 2023 –  Cartherics Pty Ltd (“Cartherics”), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has granted Shunxi Holding Group Co Ltd (“Shunxi”) a licence to develop, manufacture and commercialise Cartherics’ autologous CAR-T cell product, CTH-004, for the treatment of multiple solid tumours including […]

2023-04-28T13:00:59+10:00April 28th, 2023|

Cartherics proudly supports the White Shirt Campaign

Cartherics is hosting a White Shirt Day lunch on 8th May to help raise funds and awareness for ovarian cancer. The White Shirt Campaign officially launches on April 11th and culminates on White Shirt Day (8 May) – World Ovarian Cancer Day.

The campaign is a 15-year partnership between the Ovarian Cancer Research Foundation (OCRF) […]

2023-05-24T13:40:22+10:00April 11th, 2023|

Cartherics to present at ThymOz 2023

Cartherics will be presenting at the ThymOZ 2023 International Conference on T Cells to be held from 22 -26 March at Heron Island in Queensland, Australia. The conference covers a broad range of topics including T cell differentiation and function, stromal cell biology, immunotherapy and tissue regeneration.

Rachelle Duffin, PhD Candidate at Cartherics will be presenting […]

2023-03-22T09:32:06+11:00March 22nd, 2023|

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer

Melbourne, Victoria, Australia 27 February 2023

Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-004) for the treatment of ovarian cancer.

The clinical trial to be conducted by Peter Mac will be the first […]

2023-02-27T14:37:49+11:00February 27th, 2023|

Cartherics is ‘Turning Teal’ this February in support of ovarian cancer

Cartherics is delighted to be hosting a Teal Tea this February to raise awareness and funds for people affected by ovarian cancer.

Ovarian Cancer Australia’s Teal Ribbon Day is an initiative that aims to start conversations that change lives. It will increase awareness of the disease and help raise funds to support people affected by […]

2023-05-24T13:40:58+10:00February 22nd, 2023|

Cartherics celebrates PhD student’s success

Cartherics is delighted to announce that Saleh Almasabi has successfully completed his PhD Candidature.

Saleh’s research thesis, The role of integrin linked kinase in senescence and immunosuppressive tumor microenvironment in colon cancer’, identified that integrin-linked kinase (ILK) is associated with cancer prognosis and characterises the immunosuppressive tumor microenvironment. These findings suggest possible clinical avenues of targeting […]

2023-02-06T13:37:22+11:00February 6th, 2023|
Go to Top